RHUMBLINE ADVISERS - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 117 filers reported holding INTERSECT ENT INC in Q2 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$993,000
+14.4%
35,439
+11.5%
0.00%0.0%
Q4 2021$868,000
-15.8%
31,792
-16.1%
0.00%0.0%
Q3 2021$1,031,000
+60.1%
37,904
+0.7%
0.00%0.0%
Q2 2021$644,000
-24.0%
37,654
-7.2%
0.00%0.0%
Q1 2021$847,000
-14.4%
40,584
-6.1%
0.00%0.0%
Q4 2020$990,000
+46.9%
43,214
+4.6%
0.00%0.0%
Q3 2020$674,000
+6.1%
41,299
-12.0%
0.00%0.0%
Q2 2020$635,000
+24.8%
46,924
+9.2%
0.00%0.0%
Q1 2020$509,000
-50.8%
42,988
+3.4%
0.00%
-50.0%
Q4 2019$1,035,000
+47.6%
41,580
+0.9%
0.00%
+100.0%
Q3 2019$701,000
-24.0%
41,192
+1.7%
0.00%
-50.0%
Q2 2019$922,000
-26.9%
40,495
+3.3%
0.00%0.0%
Q1 2019$1,261,000
+13.2%
39,218
-0.8%
0.00%0.0%
Q4 2018$1,114,000
+44.3%
39,547
+47.3%
0.00%
+100.0%
Q3 2018$772,000
-28.7%
26,847
-7.2%
0.00%
-50.0%
Q2 2018$1,083,000
+10.6%
28,931
+16.2%
0.00%0.0%
Q1 2018$979,000
+21.0%
24,901
-0.2%
0.00%0.0%
Q4 2017$809,000
-12.6%
24,958
-16.0%
0.00%0.0%
Q3 2017$926,000
+12.7%
29,721
+1.1%
0.00%0.0%
Q2 2017$822,000
+72.7%
29,396
+5.9%
0.00%
+100.0%
Q1 2017$476,000
+45.6%
27,771
+2.8%
0.00%0.0%
Q4 2016$327,000
-9.4%
27,012
+18.6%
0.00%0.0%
Q3 2016$361,000
+24.9%
22,771
+1.9%
0.00%0.0%
Q2 2016$289,000
-0.7%
22,341
+46.1%
0.00%0.0%
Q1 2016$291,000
-15.2%
15,293
+0.4%
0.00%0.0%
Q4 2015$343,000
+8.2%
15,228
+12.6%
0.00%0.0%
Q3 2015$317,000
-5.9%
13,528
+14.9%
0.00%0.0%
Q2 2015$337,00011,7750.00%
Other shareholders
INTERSECT ENT INC shareholders Q2 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,332,773$27,828,0005.75%
First Light Asset Management, LLC 2,036,645$42,525,0002.82%
Altium Capital Management LP 141,856$2,962,0000.82%
PURA VIDA INVESTMENTS, LLC 909,660$18,994,0000.54%
Rock Springs Capital Management LP 1,080,200$22,555,0000.49%
Novo Holdings A/S 508,922$10,626,0000.44%
Davide Leone & Partners Investment Co Ltd. 109,240$2,281,0000.28%
PURA VIDA INVESTMENTS, LLC 256,800$5,362,0000.15%
Bellevue Group AG 617,968$12,903,0000.14%
Gyon Technologies Capital Management, LP 13,318$278,0000.12%
View complete list of INTERSECT ENT INC shareholders